Duration of spinal anesthesia with bupivacaine in chronic opium abusers undergoing lower extremity orthopedic surgery

Archives of Iranian Medicine

Volumn 10, Issue 3, 2007, Pages 316-320

  Dabbagh, Ali ^a   Dahi Taleghani, Mastane ^a   Elyasi, Hedayatollah ^a   Vosoughian, Maryam ^a   Malek, Bahman ^a   Rajaei, Samira ^b   Maftuh, Hassan ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bupivaccaine; Cross tolerance; Opium abuse; Pain receptor; Spinal anesthesia

Indexed keywords

BUPIVACAINE; MIDAZOLAM; PROMETHAZINE;

ADULT; AGE DISTRIBUTION; AGED; ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ANESTHESIOLOGICAL TECHNIQUES; ANESTHETIC RECOVERY; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS TOLERANCE; DOSE TIME EFFECT RELATION; ELECTIVE SURGERY; FEMALE; HUMAN; LEG DISEASE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OPIATE ADDICTION; ORTHOPEDIC SURGERY; PAIN THRESHOLD; SEX DIFFERENCE; SPINAL ANESTHESIA;

ADULT; ANESTHESIA, SPINAL; ANESTHETICS, LOCAL; BUPIVACAINE; CASE-CONTROL STUDIES; FEMALE; HUMANS; INJECTIONS, SPINAL; LEG; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; OPIUM; ORTHOPEDIC PROCEDURES;

EID: 34547518582     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Vosoughian M, Dabbagh A, Rajaei S, Maftuh H. Duration of spinal anesth with 5% lidocaine in chronic opium abusers compared with nonabusers. Anesth Anal. 2007; 105 (2). In press.
2. Ossipov MH, Lai J, King T, Vanderah TW, Porreca F. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure. Biopolymers. 2005; 80: 319-324.
3. Gardell LR, King T, Ossipov MH, Rice KC, Lai J, Vanderah TW, et al. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neurosci Lett. 2006; 396: 44-49.
4. Ossipov MH, Lai J, King T, Vanderah TW, Malan TP Jr, Hruby VJ, et al. Antinociceptive and nociceptive actions of opioids. J Neurobiol. 2004; 61: 126-148.
5. Szeto HH, Soong Y, Wu D, Qian X, Zhao GM. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA. J Pharmacol Exp Ther. 2003; 305: 696-702.
6. Christie MJ, Williams JT, North RA. Cellular mechanisms of opioid tolerance: studies in simple brain neurons. Mol Pharmacol. 1987; 32: 633-634.
7. Bovill JC. Mechanisms of action of opioids and nonsteroidal antiinflammatory drugs. Eur J Anaesthesiol Suppl. 1997; 14: 9.
8. Wu HE, Thompson J, Sun HS, Leitermann RJ, Fujimoto JM, Tseng LF. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord. J Pharmacol Exp Ther. 2004; 310: 240-246.
9. Chen SR, Pan HL. Antinociceptive effect of morphine, but not mu-opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology. 2003; 99: 1409-1414.
10. Yoburn BC, Gomes BA, Rajashekara V, Patel C, Patel M. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor down regulation in vivo. Synapse. 2003; 47: 109-116.
11. Vanderah TW, Suenaga NM, Ossipov MH, Malan TP Jr, Lai J, Porreca F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci. 2001; 21: 279-286.
12. Xie JY, Herman DS, Stiller CO, Gardell LR, Ossipov MH, Lai J, et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci. 2005; 25: 409-416.
13. Allen RM, Dykstra LA. The competitive NMDA receptor antagonist LY235959 modulates the progression of morphine tolerance in rats. Psychopharmacology. 1999; 142: 209-214.
14. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006; 104:570-587.
15. King T, Gardell LR, Wang R, Vardanyan A, Ossipov MH, Malan TP Jr, et al. Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain. 2005; 116: 276-288.
16. Dogrul A, Bilsky EJ, Ossipov MH, Lai J, Porreca F. Spinal L-type calcium channel blockade abolishes opioid-induced sensory hypersensitivity and antinociceptive tolerance. Anesth Analg. 2005; 101: 1730-1735.
17. Lai J, Porreca F, Hunter JC, Gold MS. Voltage-gated sodium channels and hyperalgesia. Annu Rev Pharmacol Toxicol. 2004; 44: 371-397.
18. Hurley RW, Banfor P, Hammond DL. Spinal pharmacology of antinociception produced by microinjection of mu- or delta-opioid receptor agonists in the ventromedial medulla of the rat. Neuroscience. 2003; 118: 789-796.
19. Marchand F, Ardid D, Chapuy E, Alloui A, Jourdan D, Eschalier A. Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats. J Pharmacol Exp Ther. 2003; 307: 268-274.
20. Modalen AO, Westman L, Arlander E, Eriksson LI, Lindahl SG. Hypercarbic and hypoxic ventilatory responses after intrathecal administration of bupivacaine and sameridine. Anesth Analg. 2003; 96: 570-575.